Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
AMPLY Discovery
AMPLY Discovery is a biotech company leveraging AI and evolutionary biology to discover novel medicines, focusing on cancer and infectious diseases. Their proprietary AMPLYfolio AI platform digitizes…
AMPLY Discovery
AMPLY Discovery is a biotech company leveraging AI and evolutionary biology to discover novel medicines, focusing on cancer and infectious diseases. Their proprietary AMPLYfolio AI platform digitizes…
TL;DR
Headquarters: Belfast, United Kingdom
Focus: AI-driven drug discovery for cancer and infectious diseases
Proprietary platform: AMPLYfolio AI (digitizes biological diversity, links in silico discovery to bioprinting and lab validation)
Founded: 2021
Early funding: Seed + grants (reported ~£2.3M rounds and ~ $3M combined funding/grants)
Founding management includes Dr Ben Thomas (CEO/CTO) and Dermot Tierney (CFO/CCO)
Company Overview
Problem Domain
Drug discovery for cancer and infectious diseases; discovery of novel biologics from natural sequence diversity.
Founded
2021
Industry
Biotechnology
Funding Track Record
£900,000
Reported QUB spin-out funding event
£1,400,000
Reported funding round for AI drug discovery platform
5228537
Aggregated funding figure reported in company snapshot (currency USD)
Investor Signal
“Seed round led by Twin Path Ventures; other reported investors include QUBIS, Co-FundNI and British Business Bank”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week